Breast cancer subtypes defined by hormone receptor (HR) and human epidermal growth factor receptor 2 (HER2) status have been shown as not only having distinctive molecular phenotypes [2], but also having different prognoses [3]. The gene discussed is ERBB2; the disease is breast carcinoma.